The Drug Resilience Atlas is a global research platform mapping how biology, culture, law, environment, and behaviour shape resilience — across substances, stress, burnout, and modern dependency systems. Not pro-drug. Not anti-drug. Evidence-driven.
A modern, insightful survey covering sleep, stress, isolation, behavioural patterns, and recovery. Get a personal resilience profile. Compare to peers. Contribute to global signal.
Start the survey →Vote and reason on the questions society is already asking — psychedelic therapy, ADHD prescribing, AI dependency, dopamine economics. See how positions differ by region and demographic.
See current topics →A living global view of resilience trends, recovery hotspots, policy shifts, and emerging behavioural signals. Country and city level. Built on transparent metrics.
Open the map →A behavioural resilience observatory. We track resilience as a measurable property of individuals, communities, and jurisdictions — shaped by policy, services, culture, and biology — and we score it transparently using a public methodology (canonical definition, open schema, scoring engine).
Public health Behavioural science Neuroadaptation Policy intelligence Workforce resilience
Not a drug-culture forum. Not legalisation advocacy. Not a clinical decision support tool. Not a personal health record. We do not provide procurement, manufacture, or usage optimisation information. Every page with risk content links to country-specific support resources.